
Patent Foramen Ovale-Associated Stroke
Falha ao colocar no Carrinho.
Tente novamente mais tarde
Falha ao adicionar à Lista de Desejos.
Tente novamente mais tarde
Falha ao remover da Lista de Desejos
Tente novamente mais tarde
Falha ao adicionar à Biblioteca
Tente outra vez
Falha ao seguir podcast
Tente outra vez
Falha ao parar de seguir podcast
Tente outra vez
-
Narrado por:
-
De:
Sobre este áudio
A patent foramen ovale (PFO) is present in approximately 25% of all adults. Author David M. Kent, MD, MS, of Tufts Medical Center and JAMA Associate Editor David Simel, MD, MHS, discuss how to evaluate the likelihood that a PFO was causal in a patient with a cryptogenic ischemic stroke, and closure of a PFO to lower the incidence of recurrent strokes for affected patients.
Related Content:
- Patent Foramen Ovale and Stroke
- Patent Foramen Ovale and Dysarthria in a Man in His 60s
- Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA
- Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke
- Transesophageal Echocardiogram Detecting a High-Risk Patent Foramen Ovale
-----------------------------------
JAMA Editors' Summary
Ainda não há avaliações